Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Metabolic biomarkers for predicting responsiveness to FGF-18 compound

Metabolic biomarkers for predicting responsiveness to FGF-18 compound

US Patent 11513128 · Granted Nov 29, 2022

Estimated economic value: $222,450,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Type XXIII collagen assay2025
Markers useful in enrichment strategies for the treatment of osteoarthritis2025
Markers useful in enrichment strategies for the treatment of osteoarthritis2025
Markers useful in enrichment strategies for the treatment of osteoarthritis2025
Markers useful in enrichment strategies for the treatment of osteoarthritis2025
Markers useful in enrichment strategies for the treatment of osteoarthritis2025
Collagen type X alpha-1 assay2025
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound2025
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound2025
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound2025
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound2025
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound2025